BCBrendha Lang Camboim

Brendha Lang Camboim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Brendha Lang Camboim has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Development and Stability Assessment of Alternative Sugar-Free Pediatric Solution Containing Losartan Potassium

    by Bruna S. Bersagui, Gabriela A. de Oliveira, Brendha L. Camboim, Sílvia H. O. de Almeida, Márcio V. Ayres, Cássia V. Garcia

    Purpose: Losartan potassium is an antihypertensive drug commercialized only as tablets. As an alternative to the hospital pediatric extemporaneous preparations, it was developed a sugar-free oral liquid formulation containing this drug (2.0 mg/mL) in order to allow the dose adjustment, accuracy and easy administration. Methodology: The stability of formulation was evaluated at room temperature (15-30°C), refrigerated (2-8°C) and oven (40°C), during 56 days in amber glass bottles (n = 3). A stability-indicating analytical method by high performance liquid chromatography (HPLC) was used for drug determination weekly. The acceptance criterion was between 95.0% and 105.0%. Organoleptic characteristics, pH, viscosity, and microbiological content were also evaluated. Results: All samples under room and refrigerated conditions kept their pH values and microbiological content in accordance during all the period tested. However, for those at room temperature, the drug amount, formulation appearance and viscosity were adequate until the 42nd day of analysis, indicating that this was the recommended beyond-use date for the proposed solution. Conclusion: A simple and economical solution was obtained with the advantage to be sugar-free, without the cariogenic effect, and without the disadvantages of pharmaceutical suspensions, contributing to pediatric patients during hospital treatments.

  • Open Access

    Development of levothyroxine sodium pediatric oral solution driven by STEP database: Stability study and degradation products by LC-MS

    by Brendha Lang Camboim, Bruna Silveira Bersagui, Sílvia Helena de Oliveira Almeida, Márcio Vinícius Ayres, Andreas Sebastian Loureiro Mendez, Cássia Virginia Garcia


  • Open Access

    Biotransformation of Ambrisentan by A. niger and P. mineoluteum Monitored by High Performance Liquid Chromatography and Ultra High Performance Liquid Chromatography/Quadrupole Time‐of‐Flight Mass Spectrometry

    by Rafaela Martins Sponchiado, Brendha Lang Camboim, Julia Medeiros Sorrentino, Leticia Cordenonsi, Alexsandro Dallegrave, Alexandre Meneghello Fuentefria, Martin Steppe, Cássia Virginia Garcia

    The focus of the present study was the monitoring of ambrisentan (AMB) in vitro biotransformation by two fungal cultures: Aspegillus niger ATCC 9029 and Penicillium mineoluteum URM 6889. This drug is a selective endothelin Type A, receptor antagonist, used for pulmonary arterial hypertension. In vitro metabolism study was carried out by incubating AMB with fungus and culture medium under controlled conditions for further analysis of metabolites formed through an alternative method. After incubation for 240 hours with A. niger , drug was metabolized into two substances: one is known (M2) with 3.75 min retention time and another unknown (M3) at 4.37 min retention time in high performance liquid chromatography–diode array detector method (HPLC‐DAD). Structures were suggested by using ultra high performance liquid chromatography/quadrupole time‐of‐flight mass spectrometry (UHPLC‐QTOF/MS) method. When drug was submitted to biotransformation with P. mineoluteum , no different signals than those formed in the controls were observed, demonstrating it is not adequate to the purpose. The findings indicate that fungi A. niger could be used to generate mammalian metabolites of AMB on a small scale and can also be used as reference standard for identification and analytical tests of mammalian metabolites of this drug.


  • Overview of the Greenness’ Metrics used to Evaluate Analytical Methods

    by Amanda Mohr, Brendha Camboim, Andreas Mendez, Cássia Garcia, Martin Steppe

    The main goal of Green Analytical Chemistry (GAC) is to reduce the use of hazardous chemicals and waste generation in analytical procedures without compromising method performance. Over the years, several metrics tools were introduced to measure the environmental impact and greenness of analytical procedures. In this context, this paper aims to present an overview of the most used GAC metrics in analytical chemistry, highlighting their criteria, advantages, disadvantages, and comparing their applicability. After extensive research, the metrics selected to be addressed were: National Environmental Method Index (NEMI), Analytical Eco-scale, Modified Green Analytical Procedure Index (MoGAPI), and Analytical GREEnness Metric (AGREE). NEMI is one of the oldest GAC metrics, describing the greenness of the method by a simple pictogram. Analytical Eco-Scale is based on subtracting penalty points from a total score of 100 points. MoGAPI uses a pictogram made up of fifteen categories and a total score to display the greenness of the analytical procedure. AGREE is represented as a circular pictogram divided into 12 parts, where each part corresponds to a principle of GAC. Each discussed metric has its own advantages and disadvantages; however, AGREE stands out as the most widely used and comprehensive GAC metric, applicable to several techniques. Although time-consuming, ideally, the best approach is to apply all metrics in combination to gain as much information as possible.